导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 13.49% | 143/1230 |
| 近一周 | 0.15% | 322/1507 |
| 近一月 | -0.08% | 316/1481 |
| 近一季 | -0.30% | 1189/1412 |
| 近半年 | 6.91% | 222/1328 |
| 近一年 | 10.55% | 162/1219 |
| 近两年 | 27.28% | 54/1025 |
| 近三年 | 24.02% | 49/848 |
| 成立以来 | 60.63% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
4.23% 61/1314 |
2.65% 182/1383 |
7.57% 171/1469 |
- - |
| 2024 | 12.89% 14/1292 |
0.03% 816/1173 |
-1.03% 1112/1208 |
5.38% 32/1251 |
8.21% 14/1292 |
| 2023 | -2.09% 766/1121 |
1.93% 347/995 |
-0.40% 652/1035 |
-2.12% 852/1075 |
-1.47% 855/1121 |
| 2022 | -5.77% 517/955 |
-3.86% 452/793 |
2.43% 391/850 |
-3.41% 636/895 |
-0.93% 419/955 |
| 2021 | 5.46% 350/782 |
1.22% 131/692 |
1.59% 364/754 |
0.73% 534/825 |
1.81% 407/782 |
| 2020 | 7.50% 290/632 |
-0.26% 489/607 |
0.89% 329/665 |
3.44% 166/685 |
3.28% 190/708 |
| 2019 | 16.71% 83/548 |
10.83% 80/1682 |
-1.61% 1537/1825 |
2.78% 90/614 |
4.14% 100/630 |
| 2018 | -4.04% 351/500 |
- - |
-5.37% 1245/1345 |
0.21% 1112/1404 |
-2.16% 1271/1542 |
| 2017 | 5.30% 61/499 |
- - |
- - |
- - |
- - |
| 2016 | -0.45% 136/426 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 创金合信全球医药生物股票发起(QDII)C | 1.8141 | 37.76% |
| 易方达标普生物科技人民币A | 1.7328 | 28.02% |
| 永赢先锋半导体智选混合发起C | 1.2684 | 26.99% |
| 银华集成电路混合A | 1.4951 | 23.93% |
| 华商致远回报混合A | 1.6291 | 23.20% |
| 华夏中证半导体材料设备主题ETF | 1.5851 | 22.62% |
| 天弘中证半导体材料设备主题指数发起C | 1.7561 | 21.34% |
| 诺安优化配置混合A | 2.5072 | 17.29% |
| 东方低碳经济混合C | 1.2657 | 17.06% |
| 广发生物科技指数美元(QDII)A | 0.2092 | 16.76% |
| 东方红收益增强债券C VS. () |